For the best experience on the Abcam website please upgrade to a modern browser such as Google Chrome
A synthetic peptide corresponding to residues near the N-terminus of human LFA-ß2 was used as an immunogen.
This product is a recombinant rabbit monoclonal antibody.
Produced using Abcam’s RabMAb® technology. RabMAb® technology is covered by the following U.S. Patents, No. 5,675,063 and/or 7,429,487.
Our Abpromise guarantee covers the use of ab53009 in the following tested applications.
|WB||1/1000 - 1/2000. Detects a band of approximately 95 kDa.|
ab53009 has not yet been referenced specifically in any publications.